Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:15 PM
NCT ID: NCT01023256
Term: Rheumatoid arthritis
Organ System: Musculoskeletal and connective tissue disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 13.0
Notes: Worsening or flares of rheumatoid arthritis. In 8 of the 9 MOR103 subjects with RA exacerbations, this AE occurred after the last dose of MOR103 (10 days to \>12 weeks), suggesting that disease flares were related to withdrawal of active treatment.
Study: NCT01023256
Study Brief: Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 3 3 24 View
EG001 4 4 22 View
EG002 3 2 23 View
EG003 10 9 69 View
EG004 0 0 27 View